Alemtuzumab

Drug Index

Alemtuzumab, sold under the brand names Campath and Lemtrada among others, is a medication used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis.[1] In CLL, it has been used as both a first line and second line treatment.[1] In MS it is generally only recommended if other treatments have not worked.[1] It is given by injection into a vein.[1] It is a monoclonal antibody that binds to CD52, a protein present on t...

Alemtuzumab

Alemtuzumab, sold under the brand names Campath and Lemtrada among others, is a medication used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis.[1] In CLL, it has been used as both a first line and second line treatment.[1] In MS it is generally only recommended if other treatments have not worked.[1] It is given by injection into a vein.[1] It is a monoclonal antibody that binds to CD52, a protein present on t...

IBM TREATMENT THROUGH alemtuzumab

AAN Meeting in Boston April 28. alemtuzumab was used sucsesfully on patents with inclusion body myositis. I got this from an MDA handout. Do you know anything about this? So far I have hered there is no treatment for IBM that works.

NDC Database

Campath 30 mg/ml Intravenous Injection by Genzyme Corporation ## Package Codes: 58468-0357-1, 58468-0357-3 ## Active Ingredients: Alemtuzumab